Sharon Townson
Chief Tech/Sci/R&D Officer at MONTE ROSA THERAPEUTICS, INC.
Sharon Townson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 | - |
| Corporate Officer/Principal | 2020-06-30 | 2020-11-30 |
Career history of Sharon Townson
Former positions of Sharon Townson
| Companies | Position | Start | End |
|---|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 2019-03-31 | 2020-05-31 |
| Corporate Officer/Principal | 2019-03-31 | 2020-05-31 | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 2013-05-31 | 2018-11-30 |
Training of Sharon Townson
| University of Salford | Undergraduate Degree |
| University of Manchester Institute of Science & Technology | Doctorate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Sharon Townson
- Experience